SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-435740
Filing Date
2016-01-22
Accepted
2016-01-22 16:39:40
Documents
2
Group Members
ANNE-MARI PASTEROMEGA FUND IV G.P. MANAGER, LTD.OMEGA FUND IV GP, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d257563dsc13g.htm SC 13G 119189
2 EX-99.1 d257563dex991.htm EX-99.1 6684
  Complete submission text file 0001193125-16-435740.txt   127554
Mailing Address 1 ROYAL PLAZA, ROYAL AVENUE ST. PETER PORT Y7 GY1 2HL
Business Address 1 ROYAL PLAZA, ROYAL AVENUE ST. PETER PORT Y7 GY1 2HL 44 0 148 173 5806
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-88939 | Film No.: 161356599
SIC: 2834 Pharmaceutical Preparations